Silvia Piantoni Selected Research

Cholecalciferol (Vitamin D3)

3/2020	Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases.
3/2020	Is cholecalciferol a potential disease-modifying anti-rheumatic drug for the management of rheumatoid arthritis?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvia Piantoni Research Topics

Disease

10	Rheumatoid Arthritis 01/2024 - 04/2014
8	COVID-19 01/2023 - 01/2020
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 07/2013
5	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 02/2024 - 05/2012
2	Hypertension (High Blood Pressure) 01/2024 - 01/2017
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 10/2020
2	Pneumonia (Pneumonitis) 01/2023 - 10/2020
2	Synovitis 11/2022 - 01/2018
2	Inflammation (Inflammations) 01/2021 - 01/2017
1	Hypercholesterolemia 01/2024
1	Connective Tissue Diseases (Connective Tissue Disease) 12/2022
1	Lupus Nephritis 11/2022
1	Skin Manifestations 06/2022
1	Infections 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Fatigue 05/2021
1	Autoimmune Diseases (Autoimmune Disease) 03/2020
1	Pain (Aches) 03/2020
1	Pulmonary Hypertension 11/2017
1	Proteinuria 01/2017
1	Cutaneous Lupus Erythematosus 01/2017
1	Vascular System Injuries 01/2017

Drug/Important Bio-Agent (IBA)

7	Abatacept (Orencia)FDA Link 11/2022 - 04/2014
5	Colchicine FDA LinkGeneric 01/2023 - 01/2020
5	AntibodiesIBA 09/2021 - 04/2014
4	Antiphospholipid AntibodiesIBA 02/2024 - 05/2012
4	AutoantibodiesIBA 01/2024 - 04/2014
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2014
4	belimumabIBA 11/2022 - 01/2017
2	Rheumatoid FactorIBA 01/2024 - 04/2014
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2022
2	EpitopesIBA 07/2020 - 01/2020
2	Phospholipids (Phosphatides)FDA LinkGeneric 07/2020 - 01/2020
2	Vitamin D FDA LinkGeneric 03/2020 - 03/2020
2	Cholecalciferol (Vitamin D3)FDA Link 03/2020 - 03/2020
1	Peptides (Polypeptides)IBA 01/2024
1	Retinaldehyde (Retinal)IBA 01/2024
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2023
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 12/2022
1	ChemokinesIBA 11/2022
1	AntigensIBA 11/2022
1	EnzymesIBA 11/2022
1	anifrolumabIBA 06/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Modafinil (Provigil)FDA Link 05/2021
1	CytokinesIBA 01/2021
1	Anti-Idiotypic AntibodiesIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	Ritonavir (Norvir)FDA Link 10/2020
1	Lopinavir FDA Link 10/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2020
1	A-factor (Streptomyces)IBA 03/2020
1	Antirheumatic Agents (DMARD)IBA 03/2020
1	Monoclonal AntibodiesIBA 01/2019
1	ametantrone (HAQ)IBA 01/2018
1	Caffeine (No Doz)FDA LinkGeneric 11/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Prednisone (Sone)FDA LinkGeneric 01/2017
1	Angiotensin IIIBA 01/2017
1	Granzymes (Granzyme)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 04/2014
1	Immunoglobulin A (IgA)IBA 07/2013

Therapy/Procedure

5	Therapeutics 01/2024 - 04/2016